For this purpose, we evaluated the gene expression of possible molecules involved in the ER stress signaling pathways (PERK-ATF4-IRE-1) and NAFLD (FXR, SREBP-1c, FAS). This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.